Principal Scientist II
Metrum Research Group, United States
Tim has worked at Metrum Research Group since 2019, in both PK/PD and statistics. He attained his Ph.D. in Statistics from the University of Queensland, where he applied optimal design methods to PK/PD models. He then worked at Eli Lilly and Company in pharmacometrics before joining Metrum. His work involves using modeling and simulation to inform decision making in all phases of drug development across a range of therapeutic areas.
Disclosure(s): No financial relationships to disclose
The Practical Bayesian: How Bayesian Methodology is Incorporated into Clinical Drug Development
Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST
Hybrid Approaches in Pharmacometric Modeling: Integrating Maximum Likelihood and Bayesian Estimation
Wednesday, November 13, 2024
1:45 PM – 2:15 PM MST
